Position in NUVB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,117,833
-$2,696,319 QoQ
Shares Held
372,858
-66.8% QoQ
Ownership
0.106%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#61
of 242 holders
Holding Since
Mar 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NUVB Over Time
Shares Held
Position Value (USD)
Derivatives in NUVB
reported options exposure · as of Sep 30, 2023CallValue
$34,304
CallShares
25,600
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $4,631,421,099 across 322 Biotechnology names. NUVB ranks #211 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
468,410 | $232,673,299 | |
| 2 | INSM |
INSMED Inc
|
2,048,005 | $218,358,293 | |
| 3 | APGE |
Apogee Therapeutics, Inc.
|
1,491,404 | $197,954,052 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
763,880 | $184,072,163 | |
| 5 | ONC |
BeOne Medicines Ltd.
|
543,323 | $154,830,755 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
556,088 | $136,113,659 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
|
2,071,816 | $118,549,311 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
165,120 | $102,958,924 |
All Filings in NUVB
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,117,833 | 372,858 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $4,814,152 | 1,122,180 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,375,434 | 711,544 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $17,953,206 | 4,852,218 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $10,491,360 | 5,380,185 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $6,642,245 | 3,774,003 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $6,585,819 | 2,475,872 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,102,945 | 1,354,998 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,233,151 | 422,312 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,291,615 | 904,290 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $4,672,950 | 3,094,669 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $34,304 | 25,600 | Call | Sole | 2023-11-14 | |
| 2023-09-30 | $1,848,525 | 1,379,497 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $280,009 | 155,561 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $810,559 | 488,289 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $1,043,669 | 543,578 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $372,357 | 166,231 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,531,784 | 472,773 | Shares | Sole | 2022-08-15 | |
| 2021-09-30 | $3,712,301 | 373,471 | Shares | Sole | 2021-11-15 | |
| 2021-03-31 | $14,442,088 | 1,382,018 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||